MICHELE ELIZONDO: Open Payments
NPI 1023591369 · NEEDVILLE, TX. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$594 in 21 payments from 8 companies in 2025. Trend: 2023 $800 · 2024 $593 · 2025 $594
Food & beverage: $594
| Company | Payments | Amount |
|---|---|---|
| AstraZeneca Pharmaceuticals LP | 4 | $241 |
| Amgen Inc. | 6 | $134 |
| Lilly USA, LLC | 4 | $82 |
| ABBVIE INC. | 3 | $50 |
| Corcept Therapeutics | 1 | $31 |
| Novo Nordisk Inc | 1 | $20 |
| PFIZER INC. | 1 | $20 |
| Boehringer Ingelheim Pharmaceuticals, Inc. | 1 | $16 |
Products named: AIRSUPRA, OTEZLA, JARDIANCE, BREZTRI, FARXIGA, QULIPTA, Korlym, REPATHA.
Industry payments across TX — which companies pay providers there.
